欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/1494/001
药品名称Paracetamol/ASS/Coffein Kopfschmerz & Migräne 250 mg/ 250 mg/ 65 mg Filmtabletten
活性成分
    • acetylsalicylic acid 250.0 mg
    • caffeine 65.0 mg
    • paracetamol 250.0 mg
剂型Film-coated tablet
上市许可持有人GlaxoSmithKline Consumer Healthcare GmbH & Co. KG Barthstraße 4 80339 München Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Cyprus (CY)
      Panmigran 250 mg / 250 mg / 65 mg επικαλυμμένο
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Poland (PL)
    • Slovakia (SK)
    • Malta (MT)
      Panmigran 250 mg /250 mg /65 mg film-coated tablets
许可日期2009/08/12
最近更新日期2024/03/19
药物ATC编码
    • N02BA51 acetylsalicylic acid, combinations excl. psycholeptics
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase